IMMUNE PHARMACEUTICALS INC — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$0

Net Income/Loss (FY2017)

-$17.9M

Total Assets (FY2017)

$28.6M

Cash Flows from Operating Activities (FY2017)

-$11.6M

Source: IMMUNE PHARMACEUTICALS INC 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.